Companies: 10,795·Total market cap: $144.5T
BioPlus Acquisition Corp.

BioPlus Acquisition Corp.

BIOSNASDAQFinancial Services
$10.80
$-0.01(-0.05%)
Market Cap$209072163
P/E Ratio—
52W High$11.68
52W Low$10.12
SEC Filings

BioPlus Acquisition Corp. (BIOS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001856653 · BIOS · NASDAQ · as of Jun 9, 2026

Filing snapshot

73
Total Filings
SC 13G/A
Latest Form
2024-02-12
Most Recent
2022
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001856653 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-03-31
Fiscal Year End
Mar 31, 2023
Accession No.
0001193125-23-087738
Primary Document
d460879d10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001856653 · Accession 0001193125-23-087738

Latest Key Filings

10-QQuarterly Report
10-Q
2023-08-14
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2023-10-04Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO. 2 TO SCHEDULE 13G
2024-02-12
View
SC 13G/ABeneficial Ownership Report (Amended)
BIOPLUS ACQUISITION CORP 13GA
2024-02-09
View
SC 13G/ABeneficial Ownership Report (Amended)
FORM SC 13G/A
2024-02-07
View
SC 13G/ABeneficial Ownership Report (Amended)
BIOPLUS ACQUISITION CORP.
2024-01-19
View
15-12G15-12G
FORM 15-12G
2023-10-16
View
25-NSE25-NSE
25-NSE
2023-10-06
View
RWRW
RW
2023-10-04
View
8-KCurrent Report
CURRENT REPORT
2023-10-04
View
425425
425
2023-09-15
View
425425
425
2023-08-16
View
10-QQuarterly Report
10-Q
2023-08-14
View
S-4/AS-4/A
S-4/A
2023-08-01
View
425425
425
2023-07-17
View
S-4/AS-4/A
S-4/A
2023-06-30
View
425425
425
2023-06-14
View
Showing 1–15 of 71 filingsForm 4 / 144 hidden· 73 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001856653  |  Exchange: NASDAQ · Financial Services

BioPlus Acquisition Corp. (NASDAQ: BIOS) has submitted 73 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Financial Services sector company with CIK 0001856653, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is BioPlus Acquisition Corp.'s most comprehensive regulatory disclosure. The most recent BioPlus Acquisition Corp. 10-K was filed on 2023-03-31 for fiscal year ending 2023. Historical BIOS 10-K annual reports are available from 2021 through 2023.

Investors researching BioPlus Acquisition Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Financial Services
SCUA SEC Filings →ICNC SEC Filings →DPCS SEC Filings →CNDB SEC Filings →SBXC SEC Filings →OCAX SEC Filings →USCTW SEC Filings →IVCPU SEC Filings →
→ BIOS Financials→ BIOS Earnings→ BIOS Insider Trades

Frequently Asked Questions

BIOS SEC Filings · 8 questions

BioPlus Acquisition Corp. (BIOS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 73 filings and access original documents at no cost. BioPlus Acquisition Corp.'s CIK is 0001856653.

BIOS SEC filingsBioPlus Acquisition Corp. SEC documentsfind BIOS 10-K